Literature DB >> 3698095

A new etiology for visual impairment and chronic headache. The Tolosa-Hunt syndrome may be only one manifestation of venous vasculitis.

J Hannerz, K Ericson, G Bergstrand.   

Abstract

The Tolosa-Hunt syndrome is characterized by recurrent periods of painful ophthalmoplegia, dramatically ameliorated by steroid treatment. In half of the cases orbital phlebography shows characteristic changes. Ninety-six patients with orbital pain characteristic of the Tolosa-Hunt syndrome were submitted to orbital phlebography regardless of the existence of other symptoms. A pathologic phlebogram with changes typical of the Tolosa-Hunt syndrome was found in 50 patients. In 17 of these 50 patients the symptoms consisted of orbital pain only and no ophthalmoplegia. Twenty patients had pain and ipsilateral decrease of vision but no ophthalmoplegia, and 13 had painful ophthalmoplegia. Of 41 patients treated with steroid medication 39 responded dramatically with regard to the pain. Earlier findings indicate that the phlebographic changes are due to venous vasculitis, which thus may cause irreversible visual impairment but also chronic headache without ophthalmoplegia. It is concluded that the Tolosa-Hunt syndrome may be only one manifestation of a not uncommon disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698095     DOI: 10.1046/j.1468-2982.1986.0601059.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  3 in total

Review 1.  [The trigeminovascular system in the human. Cerebral blood flow, functional imaging and primary headache].

Authors:  A May
Journal:  Nervenarzt       Date:  2003-12       Impact factor: 1.214

Review 2.  Cluster headache mimics.

Authors:  Dale M Carter
Journal:  Curr Pain Headache Rep       Date:  2004-04

3.  Orbital phlebography in idiopathic intracranial hypertension and chronic tension-type headache.

Authors:  Jan Hannerz; Kaj Ericson; Dan Greitz; Pernille Hanne Bro Skejo; Gunnar Edman
Journal:  Acta Radiol Short Rep       Date:  2013-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.